Non-interventional, Prospective Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Lanreotide (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- Acronyms PLAN-A
- Sponsors Ipsen
Most Recent Events
- 01 Jun 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 30 Mar 2020 Planned initiation date changed from 1 Mar 2020 to 1 Apr 2020.
- 28 Feb 2020 Planned initiation date changed from 1 Feb 2020 to 1 Mar 2020.